Does the Mixed Opioid Receptor Antagonist Naltrexone Mitigate Stimulant-Induced Euphoria?: A Double-Blind, Placebo Controlled Trial of Naltrexone

OBJECTIVE: Supra therapeutic doses of methylphenidate (MPH) activate mu opioid receptors, which are linked to euphoria. This study assessed whether naltrexone, a mixed mu opioid antagonist, may attenuate the euphoric effects of stimulants, thereby minimizing their abuse potential in subjects with At...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Psychiatry
Autores principales: Spencer, Thomas J., Bhide, Pradeep, Zhu, Jinmin, Faraone, Stephen V., Fitzgerald, Maura, Yule, Amy M., Uchida, Mai, Spencer, Andrea E., Hall, Anna M., Koster, Ariana J., Feinberg, Leah, Kassabian, Sarah, Storch, Barbara, Biederman, Joseph
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548180/
https://ncbi.nlm.nih.gov/pubmed/29617066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.17m11609
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares